Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2106143 | 0.88 | AR (0.33) | — | |
| SCHEMBL2106563 | 0.86 | — | — | |
| SCHEMBL2106566 | 0.85 | — | — | |
| SCHEMBL2107496 | 0.85 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL1950938 | 0.82 | AR (0.37) | — | |
| SCHEMBL2105893 | 0.82 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL2106091 | 0.80 | ALDH1A1 (0.35) | HSD11B1 | |
| SCHEMBL1948538 | 0.80 | AR (0.35) | — | |
| SCHEMBL17554938 | 0.80 | AR (0.32) | — | |
| SCHEMBL17554993 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163804-B2 | Composition for preventing harmful organisms | MITSUI CHEMICALS, INC. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090162453-A1 | COMPOSITION FOR PREVENTING HARMFUL ORGANISMS | MITSUI CHEMICALS, INC (JP) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162453-A1 | COMPOSITION FOR PREVENTING HARMFUL ORGANISMS | PRDX3, CYP1A1, GSTA1 | HSD11B1 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.